HealthFDA Approves New Prostate Cancer Companion DiagnosticsFDA approves new prostate cancer companion diagnostics, FoundationOne CDx and Liquid CDx, for targeted mCRPC therapy.James Whitfield·June 2, 2026, 11:03 AM